Style | Citing Format |
---|---|
MLA | Arabameri A, Asemani D, Hadjati J. "A Structural Methodology for Modeling Immune-Tumor Interactions Including Pro- and Anti-Tumor Factors for Clinical Applications." Mathematical Biosciences, vol. 304, no. , 2018, pp. 48-61. |
APA | Arabameri A, Asemani D, Hadjati J (2018). A Structural Methodology for Modeling Immune-Tumor Interactions Including Pro- and Anti-Tumor Factors for Clinical Applications. Mathematical Biosciences, 304(), 48-61. |
Chicago | Arabameri A, Asemani D, Hadjati J. "A Structural Methodology for Modeling Immune-Tumor Interactions Including Pro- and Anti-Tumor Factors for Clinical Applications." Mathematical Biosciences 304, no. (2018): 48-61. |
Harvard | Arabameri A, Asemani D, Hadjati J (2018) 'A Structural Methodology for Modeling Immune-Tumor Interactions Including Pro- and Anti-Tumor Factors for Clinical Applications', Mathematical Biosciences, 304(), pp. 48-61. |
Vancouver | Arabameri A, Asemani D, Hadjati J. A Structural Methodology for Modeling Immune-Tumor Interactions Including Pro- and Anti-Tumor Factors for Clinical Applications. Mathematical Biosciences. 2018;304():48-61. |
BibTex | @article{ author = {Arabameri A and Asemani D and Hadjati J}, title = {A Structural Methodology for Modeling Immune-Tumor Interactions Including Pro- and Anti-Tumor Factors for Clinical Applications}, journal = {Mathematical Biosciences}, volume = {304}, number = {}, pages = {48-61}, year = {2018} } |
RIS | TY - JOUR AU - Arabameri A AU - Asemani D AU - Hadjati J TI - A Structural Methodology for Modeling Immune-Tumor Interactions Including Pro- and Anti-Tumor Factors for Clinical Applications JO - Mathematical Biosciences VL - 304 IS - SP - 48 EP - 61 PY - 2018 ER - |